Avitia Newsroom

The latest news, announcements, blogs, and learnings from Avitia.

Jump to
Press Releases
Blog
News Coverage
press

Avitia Press Releases

All Press Releases
Avitia and Genoscience Unlock Province-Wide Access to Targeted Liquid Biopsy Testing
September 23, 2025

Partnership brings Avitia’s cost-effective Follow It© panel to over 45 partner and seven Genoscience owned clinics, advancing precision cancer diagnostics in Quebec

Go to Press Release
Avitia Launches AI-Powered Platform for Rapid & Point-of-Care Cancer Testing
February 27, 2025

Avitia's groundbreaking AI-powered cancer diagnostic testing solution accelerates targeted treatments worldwide. Backed by $5M in seed funding, Avitia brings advanced, cost-effective molecular testing directly on-site, reducing turnaround times and empowering personalized oncology care. Learn more about this transformative innovation reshaping global cancer treatment.

Go to Press Release

Subscribe for Avitia Updates

Join our mailing list to stay up to date on the latest news, features, and releases.

By submitting this form, I agree to be contacted by Avitia so they can share product and industry resources with me and I acknowledge I've reviewed and accepted Avitia's privacy policy, which details how my personal information will be processed.
Thank you! Look for updates in your inbox soon.
Oops! Something went wrong while submitting the form.
blog

Avitia Blog

All Blog Posts
Industry
September 10, 2025

Liquid Biopsy Tests from Avitia, FoundationOne, and Guardant360 — A Cost-Effective Shift in Cancer Diagnostics

Discover how Avitia liquid Biopsy tests are creating a cost-effective shift in cancer diagnostics compared to FoundationOne and Guardant360
Go to Blog Post
Industry
April 9, 2025

We're Hiring! Join Avitia to Accelerate Cancer Technology by People Who Care

Avitia seeks a Bioinformatician to advance liquid biopsy technology with AI-driven tools, accelerating precision cancer diagnostics. | Avitia
Go to Blog Post
Industry
April 9, 2025

Unlocking New Treatments: How AI Is Revolutionizing Drug Repurposing and Cancer Diagnostics

Discover how AI-driven drug repurposing brings faster, more personalized care to patients and saves lives. | Avitia
Go to Blog Post
News coverage

Avitia in the News

October 2, 2025

Avitia partners with Genoscience to expand rapid cancer test access in Québec

Avitia CEO James Lumsdaine sat down with BetaKit to discuss the company's partnership with Genoscience to expand liquid biopsy cancer testing across Quebec.
Go to BetaKit Article
February 26, 2025

Avitia reprend une innovation québécoise de dépistage du cancer

Avitia CEO James Lumsdaine sat down with Les Affaires to discuss the company's launch and impact on global cancer care.
Go to Les Affaires Article
March 7, 2025

Avitia launches AI-powered cancer diagnostics platform

Avitia CEO James Lumsdaine sat down with BetaKit to discuss the company's launch and impact on global cancer care.
Go to BetaKit Article

Stay Ahead of Cancer Today

Get Started